Hopp til innhold

Selected items added to basket

Go to basket

Vaccination for Human Papillomavirus (HPV) (Indicator 22)

Published


The indicator describes the following: Availability of human papillomavirus (HPV) vaccines.


Have you found an error?

Vaccines against human papillomavirus (HPV) have been part of the Norwegian Childhood Immunisation Programme since 2009 and are offered to girls at the age of 12. The Norwegian Immunisation Registry SYSVAK maintains separate HPV vaccination coverage statistics. 

Results

HPV vaccination coverage among 16-year-old girls increased from 67 per cent to 81 per cent between 2013 and 2016. This is shown by data from the Norwegian Immunisation Registry SYSVAK.

HPV vaccine NCD.jpg

Figure 1HPV vaccination coverage among girls aged 16 years, as a percentage. Source: Norwegian Immunisation Registry SYSVAK. See table below.

Table accompanying Figure 1

2013

2014

2015

2016

67.1

76.3

78.7

81.1

Table 1HPV vaccination coverage among girls aged 16, as a percentage. Source: Norwegian Immunisation Registry SYSVAK. 

 

Data source: Norwegian Immunisation Registry SYSVAK

The data source for this indicator is the Norwegian Immunisation Registry SYSVAK. A description follows below.

Description 

The Norwegian Immunisation Registry SYSVAK maintains an overview of the individual's vaccination status and vaccination coverage in Norway. 

The Norwegian Childhood Immunisation Programme includes a range of different vaccines recommended by the health authorities for children and adolescents. Basic vaccination is mainly given to infants and young children, and booster doses for many of the vaccines are offered to school-age children.

The Norwegian Institute of Public Health is responsible for procuring the vaccines for the Norwegian Childhood Immunisation Programme and distributing them to the municipalities. Vaccination takes place at public health clinics and through the school health service and is free of charge. All administered vaccines are registered at individual level in SYSVAK.

The Norwegian Childhood Immunisation Programme publishes an annual report that includes coverage statistics, reported cases of diseases for which vaccination is provided, the type of vaccines that have been used.

Effect measure

  • Proportion who have received the HPV vaccine among girls aged 16, as a percentage. 

The vaccine is offered to girls at the age of 12.  Vaccination coverage is calculated at the age of 16. There is a follow-up programme for non-attendees. 

The vaccine against human papilloma virus (HPV) had been administered in three doses since 2009. From 2017, the vaccine has been administered in two doses.

Global indicator definition

WHO’s definition of the indicator

Indicator 22. Availability, as appropriate, if cost-effective and affordable, of vaccines against human papillomavirus, according to national programmes and policies. 

Authors and contacts

Text compiled by the Departments of Vaccine Preventable Diseases and Non-Communicable Diseases at the Norwegian Institute of Public Health.